EGFR and squamous cell carcinoma: Although the overexpression or mutation of EGFR levels has proven to be a valid predictor of treatment outcome, the response rates in selected patients remain chemoresistance or poor prognosis in squamous cell carcinomas as well as other malignancies [38–40].